{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"producer": "iLovePDF", "creator": "PDFMiner", "creationdate": "", "moddate": "2025-09-14T06:45:35+00:00", "total_pages": 280, "source": "/home/thiru/draft-oasis-e1-manual-04-28-2024_edited.pdf"}, "page_content": "Eschar Tissue \n\nA mental disturbance \n\ncharacterized by new or acutely worsening \nconfusion, disordered expression of thoughts, \nchange in level of consciousness or \nhallucinations. \n\nA fixed, false belief not shared by others that \nthe patient holds even in the face of \nevidence to the contrary. \n\nThe assessment time point completed \nwithin 2 calendar days of the discharge \ndate. \n\nHaving thoughts that are \nfragmented or not logically \nconnected. \n\nTotal amount/strength/concentration of a \nmedication given at one time or over a period of \ntime. The individual dose is the \namount/strength/concentration received at each \nadministration. The amount received over a 24-\nhour period may be referred to as the \u201cdaily \ndose.\u201d \n\nThe drug regimen review in post-acute care \nis generally considered to include \nmedication reconciliation, a review of all \nmedications a patient is currently using and \nreview of the drug regimen to identify, and if \npossible, prevent potential clinically \nsignificant medication issues. \n\nAn electronic version of a patient\u2019s medical \nhistory that is maintained by the provider over \ntime. \n\nRegeneration of the epidermis across a \nwound surface. \n\nDead or devitalized tissue that is hard or soft \nin texture; usually black, brown, or tan in color, \nand may appear scab-like. Necrotic tissue and \neschar are usually firmly adherent to the base \nof the wound and often the sides/edges of the \nwound. \n\nOASIS-E1 \nEffective 01/01/2025 \nCenters for Medicare & Medicaid Services \n\n242\n\fAppendix A \n\nFall \n\nTerm \n\nAbbreviation \n\nDefinition \n\nGlossary and Common Acronyms", "type": "Document"}}